Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Stevanato Group S.P.A. (STVN)

Stevanato Group S.P.A. (STVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Global Medical Device Packaging Market Size Expected to Reach $50 Billion By 2028 FinancialNewsMedia - Tue Sep 26, 2023

EQNX::TICKER_START (NASDAQ:STSS),(NYSE:STVN),(NYSE:WST),(NYSE:BDX),(NYSE:PFE) EQNX::TICKER_END

STSS : 0.2151 (-13.79%)
STVN : 28.12 (-0.39%)
WST : 362.69 (-0.20%)
BDX : 238.63 (+2.10%)
PFE : 27.83 (+2.39%)
Stevanato Group (STVN) Q1 Earnings Lag Estimates Zacks - Thu May 4, 2023

Stevanato (STVN) delivered earnings and revenue surprises of -7.69% and 1.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

STVN : 28.12 (-0.39%)
ESPR : 2.05 (+0.49%)
Stevanato Group Reports First Quarter 2023 Financial Results Business Wire - Thu May 4, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced...

STVN : 28.12 (-0.39%)
Stevanato Group to Present at BofA Securities Healthcare Conference Business Wire - Tue May 2, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 28.12 (-0.39%)
Will Akebia Therapeutics (AKBA) Report Negative Q1 Earnings? What You Should Know Zacks - Mon May 1, 2023

Akebia Therapeutics (AKBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AKBA : 1.2400 (+0.40%)
STVN : 28.12 (-0.39%)
Stevanato Group S.p.A. (STVN) Hit a 52 Week High, Can the Run Continue? Zacks - Tue Apr 18, 2023

Stevanato (STVN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

STVN : 28.12 (-0.39%)
Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023 Business Wire - Mon Apr 17, 2023

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced...

STVN : 28.12 (-0.39%)
Stevanato Group S.p.A. (STVN) Hits Fresh High: Is There Still Room to Run? Zacks - Thu Mar 30, 2023

Stevanato (STVN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

STVN : 28.12 (-0.39%)
CPRX : 15.18 (-0.13%)
Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market Business Wire - Tue Mar 21, 2023

Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today its collaboration...

STVN : 28.12 (-0.39%)
Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products Business Wire - Thu Mar 16, 2023

Stevanato Group S.p.A. (NYSE: STVN) a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced...

STVN : 28.12 (-0.39%)

Barchart Exclusives

Bill Gross: If You Must Buy Tech Stocks, This One Is the Best Barchart - 1 hour ago
'Bond King' Bill Gross has just given the green light to this tech giant. With its dominant market position and impressive recent earnings report, the stock is well-loved by analysts, too. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot